(Q44825277)

6 December 2017

title

Nonalcoholic fatty liver disease among patients with hypothalamic and pituitary dysfunction (English)

1 reference

metabolic dysfunction–associated steatotic liver disease

6 December 2017

1 reference

1 reference

1 reference

Leon A Adams

1

1 reference

6 December 2017

Ariel Feldstein

series ordinal

2

1 reference

6 December 2017

Keith D Lindor

series ordinal

3

1 reference

6 December 2017

Paul Angulo

series ordinal

4

1 reference

6 December 2017

language of work or name

English

0 references

publication date

1 April 2004

1 reference

6 December 2017

1 reference

6 December 2017

volume

39

1 reference

6 December 2017

issue

4

1 reference

6 December 2017

page(s)

909-914

1 reference

Mechanism of the development of obesity in animals with hypothalamic lesions.

6 December 2017

cites work

1 reference

7 January 2021

Hyperphagia in children with craniopharyngioma is associated with hyperleptinaemia and a failure in the downregulation of appetite.

1 reference

7 January 2021

Animal models of steatosis

1 reference

7 January 2021

Nonalcoholic fatty liver disease

1 reference

7 January 2021

Nonalcoholic steatohepatitis, insulin resistance, and metabolic syndrome: further evidence for an etiologic association

1 reference

7 January 2021

NASH and insulin resistance: Insulin hypersecretion and specific association with the insulin resistance syndrome

1 reference

7 January 2021

Comparisons of leptin, incretins and body composition in obese and lean patients with hypopituitarism and healthy individuals

1 reference

7 January 2021

[Development of complete liver cirrhosis in hyperphagia-induced fatty liver]

1 reference

7 January 2021

1 reference

7 January 2021

Nonalcoholic steatohepatitis: Summary of an AASLD Single Topic Conference

1 reference

7 January 2021

Growth hormone therapy and its relationship to insulin resistance, glucose intolerance and diabetes mellitus: a review of recent evidence

1 reference

7 January 2021

The role of the growth hormone-insulin-like growth factor axis in glucose homeostasis.

1 reference

7 January 2021

Non-alcoholic steatohepatitis and hepatic steatosis in patients with adult onset growth hormone deficiency

1 reference

7 January 2021

Growth hormone plasma levels in nonalcoholic fatty liver disease

1 reference

7 January 2021

Cardiovascular disease and risk factors in adults with hypopituitarism

1 reference

7 January 2021

Serum lipid and leptin concentrations in hypopituitary patients with growth hormone deficiency

1 reference

7 January 2021

Obesity associated insulin resistance occurs in hypopituitary subjects.

1 reference

7 January 2021

Clinical features and differential diagnosis of pituitary tumours with emphasis on acromegaly.

1 reference

7 January 2021

Growth hormone replacement therapy and insulin sensitivity

1 reference

7 January 2021

Elevated leptin concentrations in growth hormone-deficient hypopituitary adults.

1 reference

7 January 2021

Hypothalamic regulation of energy homeostasis

1 reference

7 January 2021

Hypothalamic obesity in humans: what do we know and what can be done?

1 reference

7 January 2021

Systemic inflammation, adipose tissue tumor necrosis factor, and leptin expression.

1 reference

7 January 2021

Leptin receptor-mediated signaling regulates hepatic fibrogenesis and remodeling of extracellular matrix in the rat.

1 reference

7 January 2021

Leptin in hepatic fibrosis: evidence for increased collagen production in stellate cells and lean littermates of ob/ob mice

1 reference

7 January 2021

Acute severe steatohepatitis related to prednisolone therapy

1 reference

7 January 2021

Identifiers

DOI

10.1002/HEP.20140

1 reference

6 December 2017

1 reference